AYOXXA
VerifiedclosedInternational biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis an biotech company commercializing innovative technology.
Launch date
–
Employees
Market cap
-
Net debt
-
Enterprise valuation
$10—15m (Dealroom.co estimates Dec 2014.)
Company register number HRB 73653 (Köln)
Cologne Nordrhein-Westfalen (HQ)
| EUR | 2015 | 2016 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 7 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| investor investor investor | $0.0 | round | |
| investor investor investor investor investor investor investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
* | N/A | Late VC | |
| Total Funding | 000k | ||
Related Content
Recent News about AYOXXA
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.